Host – Rob Fox, Chief Commercial Officer, tranScrip
Dr Chris Floyd, Executive Medical Director, Early Development, tranScrip

Rob Fox, tranScrip’s Chief Commercial Officer, joins Dr Christopher Floyd, Executive Medical Director, Early Development, to discuss one of the biggest milestones in drug development: the leap from preclinical to clinical. They’ll explore why it’s critical to weave a compelling translational narrative, design adaptive first-in-human studies, treat regulators as partners, focus on clarity over clutter in data, avoid decision paralysis and build expert teams aligned for success from day one.